Experts Aaron Gerds Abdulraheem Yacoub Alessandro M. Vannucchi Angela Fleischman Brady L. Stein Christine Spencer Craig W. Freyer Diwakar Davar Francesca Palandri Francesco Passamonti Gabriela Hobbs Ghaith Abu-Zeinah Giovanni Barosi Haifa Kathrin Al-Ali Jacqueline S. Garcia Jean-Jacques Kiladjian John Mascarenhas Jyoti Nangalia Laura Michaelis Marina Kremyanskaya Naveen Pemmaraju Norio Komatsu Prithviraj Bose Raajit K. Rampal Ruben A. Mesa Srdan Verstovsek Steffen Koschmieder Tiziano Barbui Uday Popat Types ASXL1 CALR driver mutations Chronic eosinophilic leukemia Chronic neutrophilic leukemia Essential thrombocytosis EZH2 IDH1 IDH2 JAK2 driver mutations JAK2 exon 12 deletions JAK2 exon 12 insertions JAK2 V617F MPL driver mutations MPL W515L/K MPN unclassifiable Myeloproliferative neoplasms Polycythemia vera Primary myelofibrosis SRSF2 TP53 Triple-negative U2AF1 Interventions ABT-737 Allo-HSCT Anagrelide Arsenic trioxide Aspirin Bomedemstat Busulfan Checkpoint inhibitors Chemotherapy CPI-0610 Cyclophosphamide Decitabine Fedratinib Fludarabine FT234 FT895 Hydroxyurea Hypomethylating agents Idasanutlin IFN-α IFN-γ Imetelstat Immune modulators Itacitinib JAK inhibitors KRT-232 LCL161 Lenalidomide MDM2 inhibitors Mepolizumab Methotrexate Momelotinib Navitoclax Pacritinib Panobinostat Parsaclisib Phlebotomy PI3 kinase inhibitors Pomalidomide PTG-300 PXS-5505 Ropeginterferon alfa-2b Ruxolitinib Splenectomy Thalidomide Events AACR 2020 ASCO 2020 ASH 2019 ASH 2020 EBMT 2020 EHA 2020 SOHO 2020 TCT 2021 Texas MPN Workshop TMW 2020 Trials COMBI COMFORT-I COMFORT-II CONTINUATION-PV FREEDOM FREEDOM2 IMbark INCB 18424-261 JAKARTA JAKARTA2 KRT-232-101 Low-PV MAJIC MANIFEST MITHRIDATE MOMENTUM PAC203 PEGINVERA PERSIST-1 PERSIST-2 PROUD-PV RELIEF RESPONSE RESPONSE-2 RESUME SIMPLIFY-1 SIMPLIFY-2 All |90 Articles |34 Videos |6 Podcasts